Literature DB >> 24242047

Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells.

Vincenza Rita Lo Vasco1, Martina Leopizzi, Chiara Puggioni, Carlo Della Rocca, Rita Businaro.   

Abstract

Besides the control of calcium levels, the phosphoinositide-specific phospholipases C (PI-PLCs), the main players in the phosphoinositide signalling pathway, contribute to a number of cell activities. The expression of PI-PLCs is strictly tissue specific and evidence suggests that it varies under different conditions, such as tumour progression or cell activation. In previous studies, we obtained a complete panel of expression of PI-PLC isoforms in human umbilical vein endothelial cells (HUVEC), a widely used experimental model for endothelial cells (EC), and demonstrated that the expression of the PLC genes varies under inflammatory stimulation. The fibroblast growth factor (FGF) activates the PI-PLC γ1 isoform. In the present study, PI-PLC expression in FGF-treated HUVEC was performed using RT-PCR, observed 24 h after stimulation. The expression of selected genes after stimulation was perturbed, suggesting that FGF affects gene transcription in PI signalling as a possible mechanism of regulation of its activity upon the AkT-PLC pathway. The most efficient effects of FGF were recorded in the 3-6-h interval. To understand the complex events progressing in EC might provide useful insights for potential therapeutic strategies. The opportunity to manipulate the EC might offer a powerful tool of considerable practical and clinical importance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242047     DOI: 10.1007/s11010-013-1898-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  47 in total

Review 1.  PLC regulation: emerging pictures for molecular mechanisms.

Authors:  Tom D Bunney; Matilda Katan
Journal:  Trends Biochem Sci       Date:  2010-10-01       Impact factor: 13.807

2.  Nuclear translocation of phospholipase C-delta1 is linked to the cell cycle and nuclear phosphatidylinositol 4,5-bisphosphate.

Authors:  Jonathan D Stallings; Edward G Tall; Srinivas Pentyala; Mario J Rebecchi
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

3.  Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C.

Authors:  M R Smith; Y L Liu; H Kim; S G Rhee; H F Kung
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

4.  Phosphoinositide 3-kinase-dependent regulation of phospholipase Cgamma.

Authors:  T Maffucci; M Falasca
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

5.  A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models.

Authors:  Genshi Zhao; Wei-Ying Li; Daohong Chen; James R Henry; Hong-Yu Li; Zhaogen Chen; Mohammad Zia-Ebrahimi; Laura Bloem; Yan Zhai; Karen Huss; Sheng-Bin Peng; Denis J McCann
Journal:  Mol Cancer Ther       Date:  2011-09-07       Impact factor: 6.261

6.  Lypopolysaccharide downregulates the expression of selected phospholipase C genes in cultured endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Chiappetta; C Puggioni; C Della Rocca; P Polonia; R Businaro
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.

Authors:  Millie Hughes-Fulford; Chai-Fei Li
Journal:  J Orthop Surg Res       Date:  2011-02-09       Impact factor: 2.359

Review 8.  Cardiovascular steroid actions: swift swallows or sluggish snails?

Authors:  M Christ; M Wehling
Journal:  Cardiovasc Res       Date:  1998-10       Impact factor: 10.787

9.  Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate.

Authors:  Toshikazu Shiba; Daisuke Nishimura; Yumi Kawazoe; Yuichiro Onodera; Kaori Tsutsumi; Rie Nakamura; Minako Ohshiro
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

Review 10.  Phospholipase C-eta enzymes as putative protein kinase C and Ca2+ signalling components in neuronal and neuroendocrine tissues.

Authors:  Alan J Stewart; Kevin Morgan; Colin Farquharson; Robert P Millar
Journal:  Neuroendocrinology       Date:  2007-08-30       Impact factor: 4.914

View more
  6 in total

1.  Different expression and subcellular localization of Phosphoinositide-specific Phospholipase C enzymes in differently polarized macrophages.

Authors:  Tania Di Raimo; Martina Leopizzi; Giorgio Mangino; Carlo Della Rocca; Rita Businaro; Lucia Longo; Vincenza Rita Lo Vasco
Journal:  J Cell Commun Signal       Date:  2016-07-09       Impact factor: 5.782

2.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

3.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

4.  LPS, Oleuropein and Blueberry extracts affect the survival, morphology and Phosphoinositide signalling in stimulated human endothelial cells.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Valeria Di Maio; Tania Di Raimo; Stefania Cesa; Alessandra Masci; Carlo Della Rocca
Journal:  J Cell Commun Signal       Date:  2017-04-27       Impact factor: 5.782

5.  Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines.

Authors:  V R Lo Vasco; M Leopizzi; C Della Rocca
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

6.  Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca
Journal:  J Cell Commun Signal       Date:  2014-07-30       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.